Feedback / Questions
SPX-1009 - Axim Biotech
https://www.globenewswire.com/news-release/2021/05/26/2236484/33692/en/AXIM-Biotechnologies-Completes-Pre-Clinical-Drug-Studies-on-SPX-1009-Compound-Proving-Suppression-of-Melanoma-Cells.html
May 26, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next